Clinical applications of mixed chimerism

Annals of the New York Academy of Sciences

Volumn 872, Issue , 1999, Pages 377-386

  Exner, Beate G ^a   Domenick, Michele A ^a   Bergheim, Marianne ^a   Mueller, Yvonne M ^a   Ildstad, Suzanne T ^a  

^a University of Louisville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW TRANSPLANTATION; CHIMERA; CONDITIONING; CONFERENCE PAPER; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; LEUKEMIA; MORBIDITY; MORTALITY; T LYMPHOCYTE; TOXICITY;

EID: 0033030712     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08482.x     Document Type: Conference Paper

References (39)

1. THOMAS, E.D., H.H. LOCHTE, W.C. LU & J.W. FERREBEE. 1957. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 157: 491-496.
2. KORNGOLD, B. & J. SPRENT. 1978. Lethal GvHD after transplantation across minor histocompatibility barriers in mice: prevention by removing mature T-cells from marrow. J. Exp. Med. 148: 1687-1698.
3. MARTIN, P.J., J.A. HANSEN, C.D. BUCKNER et al. 1985. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66: 664-672.
4. KAUFMAN, C.L., Y.L. COLSON, S.M. WREN et al. 1994. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow. Blood 84: 2436-2446.
5. ILDSTAD, S.T., P.A. CRILLEY, R.A. SHADDUCK et al. 1997. Graft engineering: the facilitating cell (FC) protocol in HLA mismatched BMT for hematologic malignancy. Blood 90: 484.
6. WOOD, M.L., A.P. MONACO, J.J. GOZZO & A. LIEGEOIS. 1971. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant. Proc. 3: 676-679.
7. MCCARTHY, S.A., I.J. GRIFFITH, P. GAMBEL et al. 1985. Characterization of host lymphoid cells in antibody-facilitated bone marrow chimeras. Transplantation 40: 12-17.
8. COBBOLD, S.P., G. MARTIN, S. QIN & H. WALDMANN. 1986. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323: 164-166.
9. SHARABI, Y., M. SYKES & D.H. SACHS. 1992. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant. 9: 191-197.
10. + cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning. Surgery 122: 221-227.
11. SYKES, M., G.L. SZOT, K.A. SWENSON & D.A. PEARSON. 1997. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat. Med. 3: 783-787.
12. COLSON, Y.L., H. LI, S.S. BOGGS et al. 1996. Durable mixed chimerism and tolerance by a non-lethal radiation-based cytoreductive approach. J. Immunol. 157: 2820-2829.
13. GAMMIE, J.S., S. LI, N. KAWAHARADA et al. Mixed allogeneic chimerism prevents obstructive airway disease in a rat heterotopic tracheal transplantation model. J. Hematother. In press.
14. STORB, R., C. YU, J.L. WAGNER et al. 1997. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89: 3048-3054.
15. ILDSTAD, S.T., S.M. WREN, J.A. BLUESTONE et al. 1985. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 162: 231-244.
16. RUEDI, E., M. SYKES, S.T. ILDSTAD et al. 1989. Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2øP1) irradiation chimeras. Cell. Immunol. 121: 185-195.
17. COLSON, Y.L., R.A. TRIPP, P.C. DOHERTY et al. 1998. Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC. J. Immunol. 160: 3790-3796.
18. BILLINGHAM, R.E., L. BRENT & P.B. MEDAWAR. 1953. Actively acquired tolerance of foreign cells. Nature 172: 603-606.
19. BILLINGHAM, R.E. & P.B. MEDAWAR. 1951. The technique of free skin grafting in mammals. J. Exp. Biol. 28: 385-402.
20. BILLINGHAM, R.E., H.G. LAMPHIN, P.B. MEDAWAR & H.L. WILLIAMS. 1952. Tolerance of homografts, twin diagnosis and the freemartin conditions in cattle. Heredity 6: 201.
21. OWEN, R.D. 1945. Immunogeneic consequences of vascular anastomoses between bovine twins. Science 102: 400-401.
22. STARZL, T.E., A.J. DEMETRIS, N. MURASE et al. 1992. Cell migration, chimerism and graft acceptance. Lancet 339: 1579-1582.
23. SCHLITT, H.J., J. HUNDRIESER, M. HISANAGA et al. 1994. Patterns of donor-type microchimerism after heart transplantation. Lancet 343; 1469-1471.
24. SIVASAI, K.S., Y.G. ALEVY, B.F. DUFFY et al. 1997. Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation 64: 427-432.
25. KNOBLER, H.Y., U. SAGHER, I.J. PELED et al. 1985. Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation 40: 223-225.
26. SAYEGH, M.H., N.A. FINE, J.L. SMITH et al. 1991. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann. Intern. Med. 114: 954-955.
27. NEIPP, M., B.G. EXNER & S.T. ILDSTAD. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance. Transplantation. In press.
28. LI, H., C.L. KAUFMAN, S.S. BOGGS et al. 1996. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulinitis in nonobese diabetic (NOD) mice. J. Immunol. 156: 380-388.
29. BREBAN, M., R.E. HAMMER, J.A. RICHARDSON & J.D. TAUROG. 1993. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J. Exp. Med. 178: 1607-1616.
30. SOBEL, E.S., V.N. KAKKANAIAH, P.L. COHEN & R.A. EISENBERG. 1993. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int. Immunol. 5: 1275-1278.
31. EEDY, D.J., D. BURROWS, J.M. BRIDGES et al. 1990. Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br. Med. J. 300: 908-909.
32. LIU, Y.J. & S.N. JOWITT. 1992. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation. Bone Marrow Transplant. 9: 31-33.
33. LOWENTHAL, R.M., M.L. COHEN, K. ATKINSON et al. 1993. Apparent cure of rheumatoid arthritis by bone marrow transplantation for leukemia. J. Rheumatol. 20: 137-140.
34. NELSON, J.L., R. TORREZ, F.M. LOUIE et al. 1997. Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. J. Rheumatol. Suppl. 48: 23-29.
35. WALTERS, M.C., M. PATIENCE, W. LEISENRING et al. 1996. Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335: 369-376.
36. LUCARELLI, G., M. GALIMBERTI, P POLCHI et al. 1990. New approach to bone marrow transplantation in thalassemia. Haematologica 75(Suppl 5): 111-121.
37. BRODSKY, R.A. 1998. Biology and management of acquired severe aplastic anemia. Curr. Opin. Oncol. 10: 95-99.
38. GOOD, R.A. 1987. Bone marrow transplantation for immunodeficiency diseases. Am. J. Med. Sci. 294: 68-74.
39. RINGDEN, O., C.G. GROTH, A. ERIKSON et al. 1995. Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation 59: 864-870.